Cardiovascular pharmacology

WikiDoc Resources for Cardiovascular pharmacology
Articles
Most recent articles on Cardiovascular pharmacology Most cited articles on Cardiovascular pharmacology Review articles on Cardiovascular pharmacology Articles on Cardiovascular pharmacology in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Cardiovascular pharmacology Images of Cardiovascular pharmacology Photos of Cardiovascular pharmacology Podcasts & MP3s on Cardiovascular pharmacology Videos on Cardiovascular pharmacology
Evidence Based Medicine
Cochrane Collaboration on Cardiovascular pharmacology Bandolier on Cardiovascular pharmacology TRIP on Cardiovascular pharmacology
Clinical Trials
Ongoing Trials on Cardiovascular pharmacology at Clinical Trials.gov Trial results on Cardiovascular pharmacology Clinical Trials on Cardiovascular pharmacology at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Cardiovascular pharmacology NICE Guidance on Cardiovascular pharmacology NHS PRODIGY Guidance FDA on Cardiovascular pharmacology CDC on Cardiovascular pharmacology
Books
Books on Cardiovascular pharmacology
News
Cardiovascular pharmacology in the news Be alerted to news on Cardiovascular pharmacology News trends on Cardiovascular pharmacology
Commentary
Blogs on Cardiovascular pharmacology
Definitions
Definitions of Cardiovascular pharmacology
Patient Resources / Community
Patient resources on Cardiovascular pharmacology Discussion groups on Cardiovascular pharmacology Patient Handouts on Cardiovascular pharmacology Directions to Hospitals Treating Cardiovascular pharmacology Risk calculators and risk factors for Cardiovascular pharmacology
Healthcare Provider Resources
Symptoms of Cardiovascular pharmacology Causes & Risk Factors for Cardiovascular pharmacology Diagnostic studies for Cardiovascular pharmacology Treatment of Cardiovascular pharmacology
Continuing Medical Education (CME)
CME Programs on Cardiovascular pharmacology
International
Cardiovascular pharmacology en Espanol Cardiovascular pharmacology en Francais
Business
Cardiovascular pharmacology in the Marketplace Patents on Cardiovascular pharmacology
Experimental / Informatics
List of terms related to Cardiovascular pharmacology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Scope

• 5% of questions of the boards

Pharmacokinetics

• Potency vs Efficacy: Potency is meaningless, effect of drug per mg. Efficacy is the clinical effectiveness of drug.
• PK is effect of the body on the drug.
• Drug distribution: muscle high in water content. Women have less muscle mass. Older patients have less muscle mass. Elderly women have less total body water. Water soluble drugs are associated with a higher drug effect (eaxample alcohool). Do not diffuse into brain. Very important in beta blockers, they are hydrophilic.
• Lipophilic drugs:Cross into CNS. Lopressor, propranolol

Hydrophilic

• In intravascular space
• Cleared by kidney
• Dont cross blood brain barrier

Atenolol, hadolol, sotalol

Metabolism

• Liver C34 in half patients
• grapefruit juice affects intestinal system, but not liver. Intestinal cytochrome CYP3A4. (dihydropiridine CCBs,

lova, simva, cyclosporine, tacrolimus, sildenafil can be affected. May increase drug levels